Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.86Price to Book
VS
Market
Sector
Industry
History
$ 1.79Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information
Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCOHERUS ONCOLOGY INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CHRS - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 119.83M | $ 102.74M | 0.86 |
| 3/31/2025 | $ -183.47M | $ 118.25M | 0 |
| 12/31/2024 | $ -131.99M | $ 106.16M | 0 |
| 9/30/2024 | $ -87.97M | $ 83.41M | 0 |
| 6/30/2024 | $ -84.11M | $ 148.62M | 0 |
| 3/31/2024 | $ -81.84M | $ 243.22M | 0 |
| 12/31/2023 | $ -193.43M | $ 250.23M | 0 |
| 9/30/2023 | $ -133.6M | $ 394.23M | 0 |
| 6/30/2023 | $ -174.76M | $ 409.99M | 0 |
| 3/31/2023 | $ -196.51M | $ 655.71M | 0 |
Key Performance Insights, Last 5 Years
- COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) P/B stands at 5.15.
- Over the past 5 years, COHERUS ONCOLOGY INC's average P/B has been 12.27.
- The median P/B for COHERUS ONCOLOGY INC during this period was 7.47
- COHERUS ONCOLOGY INC reached its highest P/B over the past 5 years at 54.36.
- The lowest P/B recorded by COHERUS ONCOLOGY INC in the same timeframe 0.86
COHERUS ONCOLOGY INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for COHERUS ONCOLOGY INC is calculated as follows: Market Cap [ $ 1.32B ] / Equity [ $ 255.73M ]
(=) P/B [ 5.15 ] CHRS - Price to Book, Last 5 years
0.86
Minimum
Jun 30, 2025
54.36
Maximum
Mar 31, 2022
12.27
Average
7.47
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |